Brief: Xintela Announces Positive Preclinical Results In Glioblastoma Project

Xintela AB

11/12/2019 12:26

Dec 11 (Reuters) - Xintela AB  XINT.ST :
    * POSITIVE PRECLINICAL RESULTS IN XINTELA'S GLIOBLASTOMA
PROJECT
    * ANNOUNCES POSITIVE PRECLINICAL RESULTS IN GLIOBLASTOMA
PROJECT
    * DEVELOPED FUNCTION-BLOCKING ANTIBODIES THAT BIND TO
COMPANY'S
TARGET INTEGRIN A10B1 AND IDENTIFIED AN ANTIBODY THAT SUPPRESSES
GROWTH OF GLIOBLASTOMA TUMORS IN A PRECLINICAL MODEL
    * FUNCTION BLOCKING ANTIBODY TARGETING INTEGRIN A10B1
INHIBITS
FUNCTION OF GLIOBLASTOMA CELLS INCLUDING MIGRATION AND
SIGNIFICANTLY SUPPRESSES GROWTH OF GLIOBLASTOMA TUMORS IN AN
ANIMAL MODEL

Source text for Eikon:  ID:nBQN1lHKKY 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))